(1 - 17 von 17
)
SWITCH Study of Efficacy and Safety of Sorafenib/Sunitinib ...European Society for Medical Oncology
www.esmo.org
— Kirsten Hauswald: No relevant relationships to disclose. Martin Indorf: No relevant relationships to disclose. Dana Gottstein: No relevant ...
sortiert nach Relevanz / Datum